This federal contract award, valued at $203,950.00, was issued by the Defense Health Agency (DHA) to Biorich Medical, Inc. for the provision of platelet-rich plasma (PRP) kits and related equipment. The contract, which does not have any set-aside designation, is a firm fixed-price purchase order with a period of performance ending on March 25, 2029.
Biorich Medical, Inc., a for-profit subchapter S corporation, supplies medical devices and supplies to federal government customers, including the Department of Defense. The PRP kits are used by military hospitals and clinics to treat musculoskeletal injuries in active duty service members, helping to accelerate healing and reduce the need for additional medical interventions.
This contract award is likely part of the DHA's efforts to provide advanced medical treatments and technologies to support the health and readiness of the U.S. Armed Forces.
Generated 11/20/24, 9:15 AM